LSD

Lysergic acid diethylamide (LSD-25), commonly known as acid, is a semisynthetic psychedelic compound first synthesized by Albert Hofmann at Sandoz Laboratories (Basel, Switzerland) on November 16, 1938, and first intentionally ingested on April 19, 1943 — “Bicycle Day.” It is one of the most potent psychoactive substances known, producing profound alterations in perception, cognition, and consciousness at doses measured in micrograms.

Discovery and Early Research

Hofmann synthesized LSD-25 as the twenty-fifth compound in a series of lysergic acid derivatives while researching ergot alkaloids (derived from Claviceps purpurea, a fungus parasitic on grain). The significance of this ergot lineage is enormous: the same fungal family has been proposed as the active ingredient in the kykeon sacrament of the Eleusinian_Mysteries (see Entheogen_Hypothesis).

In the 1950s and 1960s, LSD was investigated as a psychiatric tool for treating alcoholism, depression, and end-of-life anxiety, with promising results. Over 1,000 peer-reviewed papers were published before research was politically curtailed.

LSD and MKUltra

The CIA’s MKUltra program (1953–1973) covertly administered LSD to unwitting subjects — soldiers, prisoners, mental patients, and in some cases random civilians — as part of its search for a reliable “truth serum” and mind-control agent. Key operations included:

  • Operation Midnight Climax — CIA-funded brothels where clients were dosed with LSD and observed through one-way mirrors
  • Dr. Frank Olson — A biochemist who was dosed without consent and subsequently died under suspicious circumstances (officially a suicide, later reopened as possible homicide)
  • Depatterning — Dr. Donald Ewen Cameron’s experiments at McGill University combining LSD with electroshock, sensory deprivation, and psychic driving

The MKUltra program represents the ultimate Inverted_Initiation — the weaponization of a sacred entheogenic catalyst for purposes of control, coercion, and ego-destruction without subsequent integration.

LSD and the Entheogen Hypothesis

The Entheogen_Hypothesis — developed across multiple sources in this archive (Wasson, Hofmann, Ruck, Hillman, Sayin) — argues that LSD’s ergot-alkaloid ancestry connects it directly to the sacramental traditions of antiquity:

  • The kykeon of the Eleusinian_Mysteries may have contained an ergot-derived psychoactive (see Road_to_Eleusis_Review_Webster_1999)
  • The Greco-Roman tradition of widespread, legal entheogen use provides the historical substrate (see The_Chemical_Muse_Hillman)
  • The phenomenology of high-dose LSD experiences — ego dissolution, encounter with autonomous archetypal entities, unitive mystical states — parallels the documented effects of ancient initiatory rites

Pharmacological Profile

PropertyValue
Chemical classLysergamide (ergoline derivative)
Active dose25–250 μg (microgram range)
Duration8–12 hours
Primary mechanism5-HT₂A receptor partial agonist
Key effectsVisual hallucinations, synesthesia, ego dissolution, time distortion, mystical experiences

See Also